You have full access to this article via your institution. We studied 11 adult patients with AML who were primarily refractory to standard chemotherapy: four patients (36%) showed FLT3-ITD mutations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback